About Us
What Is ChemMine Therapeutics?
ChemMine Therapeutics is a computational drug discovery platform providing in silico solutions for
structure- and ligand-based drug design, SAR analysis, hit-to-lead and lead optimization,
molecular dynamics simulations, virtual screening, chemoinformatics,
ADMET and toxicity prediction, and AI-driven modeling. We also support
Structure-Based Drug Design
Ligand-Based Drug Design
SAR Analysis
Hit-to-Lead
Lead Optimization
Molecular Dynamics Simulations
Virtual Screening
Chemoinformatics
ADMET Prediction
Toxicity Prediction
AI-Driven Modeling
Small-Molecule Synthesis Support
Chemical Sourcing & Purchasing
Academic Collaborations
Structure-Based Drug Design
Ligand-Based Drug Design
SAR Analysis
Hit-to-Lead
Lead Optimization
Molecular Dynamics Simulations
Virtual Screening
Chemoinformatics
ADMET Prediction
Toxicity Prediction
AI-Driven Modeling
Small-Molecule Synthesis Support
Chemical Sourcing & Purchasing
Academic Collaborations
Our Team
Dr. Muhammad Haseeb
Founder & CEO
Ph.D. (Medical Science). Computational drug discovery scientist with expertise in CADD, AI/ML, MD simulations, transcriptomics. 550+ citations, 30+ publications.